Cortech Revenue and Competitors

Cortech, Inc. is a biopharmaceutical company whose primary focus was the discovery and development of novel therapeutics for the treatment of inflammatory disorders. Specifically, Cortech directed its research and development efforts toward protease inhibitors and bradykinin antagonists. In response to disappointing test results and its loss of collaborative partner support, Cortech implemented a series of reductions in force and effectively discontinued all internal research and development activities. Cortech no longer has the staff or operative facilities required to recommence internal research and development activities. Its strategy is to seek collaborative partners to conduct and fund its future research and development or to sell the rights to certain of the compounds in its portfolio to third parties. At the same time, Cortech is seeking to redeploy its assets into an operating business.